Amazon is trying to sell everything to us: buy a pharmaceutical company



[ad_1]

Amazon buys the online pharmacy chain PillPack, a move that could disrupt the business of traditional pharmacies, reports Expansión.

PillPack has licenses in 50 US states. Provide drugs to clients in previously classified doses, designed to facilitate multiple medications per day.

The economic details of the transaction are not yet known.

It was expected that Amazon's adventure in the pharmaceutical industry last January, Amazon's CEO Jeff Bezos, the richest man of the world, creates a health care company with JPMorgan Chase from Warren Buffett and Berkshire Hathaway.

The PillPack agreement already scares investors in the two major drugstore chains

The CVS chain has dropped 8% in early operations, while Walgreens Boots Alliance, the most frequent member of the Dow Jones fell by nearly 10%

. fall after reporting lower sales in the same stores in its US pharmacies.

Rite Aid's shares also fell, as did the shares of larger drug distributors Cardinal Health and AmerisourceBergen on the New York Stock Exchange

These health care and other shares rose a few months ago after rumors wanted that Amazon was not interested in selling prescription drugs.

The PillPack comes just a week after CVS announced that it will start delivering prescriptions to people's homes, a response to growing competition from PillPack and Capsule, another online pharmacy company.

The above sections are cast under the responsibility of the participants. Help us maintain a healthy exchange of ideas by denouncing, by means of an icon on the flag, each participation that you consider inappropriate. If the comment is not in accordance with THE RULES it will be eliminated. See here the regulation .

Welcome to our comments service. We invite you to analyze, comment on and question the articles and reports published by El Diario. To maintain a healthy exchange of ideas for all our users, it is necessary that you follow the rules that we detail below. By participating in the commenting service, you agree to the application of these rules.

You agree that you are solely responsible for the content you post.

Will not intentionally post content that violates any copyright, trademark, patent or other intellectual property of any third party.

Will not disseminate defamatory, obscene or aggressive content that violates the right of a third party to privacy under municipal, state, federal or even international laws or that is considered inappropriate. It will indemnify Paso del Norte Publications (*), its employees and affiliates for all claims and / or dats (including, but not limited to, attorney fees) that are submitted by third parties in relation to the content you have published. It will not write discriminatory content to other people because of their gender, race, ethnicity, nationality, religion, sexual preference, disability or any other category.

You understand and agree that El Diario is not responsible for the content published by third parties.
It is understood that in the discussion forums, El Diario monitors the published content and reserves the right to delete, edit or modify content that appears inappropriate for any reason without seeking the consent of the author. We reserve the right, by our own criteria, to remove a user's right to post content on our site.

Understand and accept that discussion forums should be used for non-commercial purposes.
He will not ask for economic resources or support. It will not promote commercial companies or carry out commercial activities of any kind in our discussion forums.

You understand and agree that the use of any information obtained through the discussion forums is at your own risk.
The Journal does not endorse the content that users distribute, and can not and will not be responsible for its accuracy.

With each publication, you grant to El Diario without royalties the irrevocable, perpetual, exclusive and totally sublime license to use, reproduce, modify, adapt, publish, translate, create derivative works to, distribute, execute and display such content in its entirety or parts worldwide and incorporate it into their work anyway currently known or developed thereafter.

[ad_2]
Source link